Neuropathic Orofacial Pain
Burning Mouth Syndrome
Burning mouth syndrome is a neuropathic pain condition characterized by a persistent burning sensation in the oral mucosa without visible mucosal pathology. It is classified as a neuropathic pain disorder — not an infection, not a deficiency, and not a psychogenic complaint. Accurate differentiation between primary and secondary BMS determines the treatment trajectory.
Symptom Profile
Recognizing the Burning Mouth Presentation
- Persistent burning sensation of the tongue (dorsal, lateral borders), palate, lips, or oral mucosa — most commonly bilateral
- Absent or minimal visible mucosal changes on clinical examination (this is a diagnostic hallmark)
- Pain typically absent during sleep but present upon waking and escalating throughout the day
- Dysgeusia — persistent metallic, bitter, or otherwise altered taste sensation
- Xerostomia or subjective dry mouth complaints despite objectively normal salivary flow
- Association with comorbid conditions: anxiety, depression, nutritional deficiencies, or medication use
- Often follows a pattern of progression: taste alteration, then burning, then dry mouth over months
The defining characteristic of BMS is the dissociation between subjective symptoms and objective findings. The mucosa appears clinically normal. This discrepancy frequently leads to a prolonged diagnostic odyssey — patients may undergo repeated dental evaluations, antifungal treatments, and vitamin supplementation without resolution, because the underlying mechanism is neuropathic rather than infectious or nutritional.
Pathophysiology
The Mechanism: Neuropathic, Not Infectious
Burning mouth syndrome is classified as a neuropathic pain condition within the ICOP taxonomy. Research points to peripheral and central neuropathic mechanisms — specifically, dysfunction of small-diameter nerve fibers (C and A-delta fibers) that innervate the oral mucosa, combined with alterations in central pain processing.
In many patients with BMS, quantitative sensory testing reveals altered thermal and mechanical detection thresholds in the burning area — evidence of peripheral nerve fiber dysfunction. Imaging studies have demonstrated changes in central pain modulation pathways, suggesting that the nervous system itself is generating the pain signal in the absence of peripheral tissue damage.
Contributing Factors
- Peripheral neuropathy of small-diameter oral mucosal nerve fibers
- Central sensitization and altered pain modulation in the trigeminal system
- Neurotransmitter dysregulation — particularly dopamine and serotonin pathways
- Hormonal changes (postmenopausal estrogen decline) as a precipitating factor
- Anatomical changes in the peripheral receptor density of the oral mucosa
Why This Classification Matters
- Neuropathic pain responds to different pharmacological agents than inflammatory or infectious conditions
- Treatment targeting nerve function (clonazepam, gabapentinoids, SSRIs) has a stronger evidence base than topical antifungals or vitamin supplementation for primary BMS
- Misclassification leads to treatment sequences that address the wrong mechanism, prolonging suffering
- Recognition of the neuropathic mechanism validates the patient's experience and directs the diagnostic workup appropriately
Diagnostic Taxonomy
Primary vs. Secondary Burning Mouth Syndrome
The ICOP taxonomy distinguishes between primary BMS (intrinsic neuropathic mechanism, no identifiable local or systemic cause) and secondary BMS (oral burning attributable to a specific local or systemic etiology). This distinction is essential because secondary causes are potentially reversible when the underlying factor is addressed.
Primary BMS
No identifiable local or systemic cause. The burning sensation is attributed to intrinsic neuropathic dysfunction of the trigeminal nerve system.
- Bilateral burning — tongue most common site
- No visible mucosal lesions
- Normal laboratory values for iron, B12, folate, zinc, glucose, thyroid
- Normal salivary flow rates
- Symptoms follow a characteristic diurnal pattern
Secondary BMS — Identifiable Causes
Oral burning caused by a specific local or systemic factor. Treatment addresses the underlying etiology.
- Medication-induced: ACE inhibitors, SSRIs, antiretrovirals, antihypertensives
- Nutritional deficiencies: iron, vitamin B12, folate, zinc
- Mucosal conditions: oral lichen planus, candidiasis, geographic tongue
- Endocrine disorders: diabetes mellitus, hypothyroidism
- Mechanical factors: denture irritation, parafunctional habits, xerostomia from radiation or Sjogren's syndrome
Clinical Protocol
Diagnostic Approach
Detailed symptom mapping — location, quality, temporal pattern, severity. Complete oral mucosal examination to identify or rule out visible pathology. Thorough medication review for xerogenic or neuropathic agents. Assessment of psychosocial comorbidities.
Targeted blood panel to screen for secondary causes: complete blood count, fasting glucose, HbA1c, iron studies, vitamin B12, folate, zinc, thyroid function (TSH, free T4). Salivary flow rate measurement. Fungal culture when candidiasis is clinically suspected.
Assessment of thermal detection thresholds (warm, cold), mechanical detection thresholds, and pain thresholds in the burning area compared to control sites. Altered thresholds confirm neuropathic involvement and differentiate central from peripheral mechanisms.
Integration of all findings to classify as primary BMS, secondary BMS (with specific etiology identified), or BMS with overlapping neuropathic mechanisms. Diagnostic protocol matched to the confirmed mechanism — addressing secondary causes directly, and targeting neuropathic pathways for primary BMS.
Persistent oral burning that has not responded to antifungal treatment, vitamin supplementation, or dental adjustments may reflect an underlying neuropathic mechanism. Systematic evaluation can identify the cause and direct the appropriate treatment pathway.
Return to Symptom Triage